Essa Pharma Inc logo

EPIX

Essa Pharma Inc

$2.91

Earnings Summary

Revenue
$0Mn
Net Profits
$-10.85Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Essa Pharma Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, Essa Pharma Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Essa Pharma Inc’s net profit jumped 16.28% since last year same period to $-10.85Mn in the Q1 2022. On a quarterly growth basis, Essa Pharma Inc has generated -19.31% fall in its net profits since last 3-months.

Net Profit Margins:

Essa Pharma Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2022. On a quarterly growth basis, Essa Pharma Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Essa Pharma Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.27
EPS Estimate Current Year
-0.27

Highlights

EPS Estimate Current Quarter:

Essa Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.27 - a -8% fall from last quarter’s estimates.

EPS Estimate Current Year:

Essa Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.27.

Key Ratios

Key ratios of the Essa Pharma Inc post its Q2 2022 earnings

Return on Assets (ROA)
-0.13
Return on Equity (ROE)
-0.2
Dividend Per Share (DPS)
0

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Essa Pharma Inc’s return on assets (ROA) stands at -0.13.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Essa Pharma Inc’s return on equity (ROE) stands at -0.2.

Dividend Per Share (DPS):

Essa Pharma Inc declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
-0.25
-0.25
0%

Company Information

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer.

Organisation
Essa Pharma Inc
Employees
25
Industry
Health Technology